KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diebold Nixdorf (DBD) Common Equity (2016 - 2025)

Diebold Nixdorf's Common Equity history spans 17 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 18.29% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 18.29%, while the annual FY2025 figure was $1.1 billion, 18.29% up from the prior year.
  • Common Equity reached $1.1 billion in Q4 2025 per DBD's latest filing, down from $1.1 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.1 billion in Q3 2025 to a low of -$2.1 billion in Q2 2023.
  • Average Common Equity over 5 years is -$277.8 million, with a median of -$48.8 million recorded in 2025.
  • The largest YoY upside for Common Equity was 542.28% in 2025 against a maximum downside of 4336.36% in 2025.
  • A 5-year view of Common Equity shows it stood at -$837.0 million in 2021, then soared by 101.17% to $9.8 million in 2022, then surged by 10241.84% to $1.0 billion in 2023, then decreased by 8.26% to $929.8 million in 2024, then increased by 18.29% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for DBD's Common Equity are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $79.0 million (Q2 2025).